BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 27069189)

  • 1. In vitro model of predicting metastatic ability using tumor derived extracellular vesicles; beyond seed soil hypothesis.
    Bhadresha K; Upadhyay V; Brahmbhatt J; Mughal MJ; Jain N; Rawal R
    Sci Rep; 2022 Nov; 12(1):20258. PubMed ID: 36424413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic Adenocarcinoma of the Lung Mimicking Miliary Tuberculosis and Pott's Disease.
    Khan D; Saddique MU; Paul T; Murshed K; Zahid M
    Cureus; 2021 Jan; 13(1):e12869. PubMed ID: 33633898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the Relationship of GDF-15 with Clinical Characteristics, Cardinal Features, and Survival in Multiple Myeloma.
    Banaszkiewicz M; Małyszko J; Batko K; Koc-Żórawska E; Żórawski M; Dumnicka P; Jurczyszyn A; Woziwodzka K; Tisończyk J; Krzanowski M; Małyszko J; Waszczuk-Gajda A; Drożdż R; Kuźniewski M; Krzanowska K
    Mediators Inflamm; 2020; 2020():5657864. PubMed ID: 33144847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Biomarkers of Ferric Management in Multiple Myeloma and Kidney Disease-Associated Anemia.
    Banaszkiewicz M; Małyszko J; Vesole DH; Woziwodzka K; Jurczyszyn A; Żórawski M; Krzanowski M; Małyszko J; Batko K; Kuźniewski M; Krzanowska K
    J Clin Med; 2019 Nov; 8(11):. PubMed ID: 31683939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periostin: A Matricellular Protein With Multiple Functions in Cancer Development and Progression.
    González-González L; Alonso J
    Front Oncol; 2018; 8():225. PubMed ID: 29946533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk factors of bone metastases in patients with lung cancer.
    Zhou Y; Yu QF; Peng AF; Tong WL; Liu JM; Liu ZL
    Sci Rep; 2017 Aug; 7(1):8970. PubMed ID: 28827719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a Patient-Derived Xenograft (PDX) of Breast Cancer Bone Metastasis in a Zebrafish Model.
    Mercatali L; La Manna F; Groenewoud A; Casadei R; Recine F; Miserocchi G; Pieri F; Liverani C; Bongiovanni A; Spadazzi C; de Vita A; van der Pluijm G; Giorgini A; Biagini R; Amadori D; Ibrahim T; Snaar-Jagalska E
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27556456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tartrate-resistant acid phosphatase isoform 5b (TRACP 5b) as a serum maker for cancer with bone metastasis.
    Chao TY; Wu YY; Janckila AJ
    Clin Chim Acta; 2010 Nov; 411(21-22):1553-64. PubMed ID: 20599857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Novel markers in osteo-oncology: the tartrate resistant acid phosphatase in myeloma bone disease].
    Strippoli S; Stucci S; Dammacco F; Silvestris F
    Recenti Prog Med; 2011 Feb; 102(2):88-95. PubMed ID: 21513124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing of a Novel Cancer Metastatic Multiplex Panel for the Detection of Bone-metastatic Disease - a Pilot Study.
    Windrichova J; Fuchsova R; Kucera R; Topolcan O; Fiala O; Finek J; Slipkova D; Karlikova M; Svobodova J
    Anticancer Res; 2016 Apr; 36(4):1973-8. PubMed ID: 27069189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of bone scintigraphy with bone markers in the diagnosis of bone metastasis in lung carcinoma patients.
    Ebert W; Muley T; Herb KP; Schmidt-Gayk H
    Anticancer Res; 2004; 24(5B):3193-201. PubMed ID: 15510610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of serum bone turnover markers in prostate cancer patients with bone metastasis.
    Kamiya N; Suzuki H; Yano M; Endo T; Takano M; Komaru A; Kawamura K; Sekita N; Imamoto T; Ichikawa T
    Urology; 2010 Jun; 75(6):1446-51. PubMed ID: 20206975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma.
    Terpos E; de la Fuente J; Szydlo R; Hatjiharissi E; Viniou N; Meletis J; Yataganas X; Goldman JM; Rahemtulla A
    Int J Cancer; 2003 Sep; 106(3):455-7. PubMed ID: 12845688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tartrate-resistant acid phosphatase 5b activity is a useful bone marker for monitoring bone metastases in breast cancer patients after treatment.
    Chung YC; Ku CH; Chao TY; Yu JC; Chen MM; Lee SH
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):424-8. PubMed ID: 16537696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of serum bone resorption markers in the diagnosis of skeletal metastasis.
    Koizumi M; Takahashi S; Ogata E
    Anticancer Res; 2003; 23(5b):4095-9. PubMed ID: 14666607
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.